Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, 
walking and exercise 
support for people with lower limb weakness or paralysis; and is used by people who have suffered 
a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis.
Rex Bionics has worked with physiotherapists to develop the practice of Robot-Assisted Physiotherapy, 
also known as REXERCISES. In a REXERCISE session, REX lifts patients from a sitting position into a
 robot-supported standing position, allowing them to take part in a set of supported walking and
 stretching exercises and core and upper body strengthening and conditioning exercises, designed by
 specialist physiotherapists.
Rex Bionics is pleased to announce the commencement of the RAPPER IV Clinical trial at 
East Kent Hospitals University. RAPPER IV is a feasibility trial designed to evaluate a balance
 rehabilitation program enabled by REX in patients with Multiple Sclerosis. This trial follows on from the
 successful RAPPER III trial.
Participants, partners and spouses will also be invited to take part in a qualitative study to gain further
 insight into their experience of using the REX in neuro-rehabilitation.
The trial will take place at Kent & Canterbury Hospital over a period of 7 weekends from February 2019
The trial is being led by Dr Mohamed Sakel FRCP (UK) Chief Investigator, Director and Consultant
 Physician in Neuro-rehabilitation. Dr Sakel says “I am excited to be following up on the promising work
 done previously to see how a robotic exoskeleton can help in rehabilitation for people with MS.”. 
Dr Sakel acknowledges the moral support and encouragement received from the local charity MS Therapy
 Centre of Canterbury, UK.
Rex Bionics Chief Executive, Dr Charles Carignan says “REX offers assistance to a wide range of 
patients in rehabilitation clinics and we are very happy to be working once again with Dr Sakel’s team at
 East Kent and his MS patients.”
For further details on the study please contact Dr Mohamed Sakel
For more information on Rex Bionics please contact Tracey White, General Manager